We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ariad Sues Amgen, Wyeth Over Enbrel

Law360 (April 16, 2007, 12:00 AM EDT) -- Expanding an already contentious biotechnology dispute, drug maker Ariad Pharmaceuticals Inc. has filed a new patent infringement lawsuit against rivals Amgen Inc. and Wyeth over Amgen's popular anti-arthritis drugs, Enbrel and Kineret.

Filed Friday in the U.S. District Court for the District of Delaware, the lawsuit accuses Amgen and Wyeth of trampling Ariad’s patent for cell-signaling technology, which was issued in 2002 and expires in 2019.

The lawsuit was filed one year after Amgen issued a preemptive strike against Ariad in the same court. While the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.